NasdaqCM:AMEH

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Apollo Medical Holdings, Inc., a physician-centric integrated population health management company, provides medical care services. More Details


Snowflake Analysis

Solid track record with adequate balance sheet.


Similar Companies

Share Price & News

How has Apollo Medical Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: AMEH has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

-1.3%

AMEH

0.7%

US Healthcare

-1.2%

US Market


1 Year Return

23.2%

AMEH

22.1%

US Healthcare

19.5%

US Market

Return vs Industry: AMEH exceeded the US Healthcare industry which returned 22.1% over the past year.

Return vs Market: AMEH exceeded the US Market which returned 19.5% over the past year.


Shareholder returns

AMEHIndustryMarket
7 Day-1.3%0.7%-1.2%
30 Day4.6%6.8%5.8%
90 Day10.4%4.9%8.1%
1 Year23.2%23.2%23.7%22.1%22.3%19.5%
3 Yearn/a34.2%28.5%43.6%34.0%
5 Yearn/a64.2%52.4%87.3%66.1%

Price Volatility Vs. Market

How volatile is Apollo Medical Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Apollo Medical Holdings undervalued compared to its fair value and its price relative to the market?

39.2%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: AMEH ($18.08) is trading below our estimate of fair value ($29.72)

Significantly Below Fair Value: AMEH is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: AMEH is poor value based on its PE Ratio (29.8x) compared to the US Healthcare industry average (23.6x).

PE vs Market: AMEH is poor value based on its PE Ratio (29.8x) compared to the US market (19x).


Price to Earnings Growth Ratio

PEG Ratio: AMEH is good value based on its PEG Ratio (0.9x)


Price to Book Ratio

PB vs Industry: AMEH's PB Ratio (3.2x) is in line with the US Healthcare industry average.


Next Steps

Future Growth

How is Apollo Medical Holdings forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

32.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: AMEH's forecast earnings growth (32.6% per year) is above the savings rate (2.2%).

Earnings vs Market: AMEH's earnings (32.6% per year) are forecast to grow faster than the US market (22.1% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: AMEH's revenue (3.9% per year) is forecast to grow slower than the US market (10% per year).

High Growth Revenue: AMEH's revenue (3.9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if AMEH's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Apollo Medical Holdings performed over the past 5 years?

1.5%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: AMEH has a large one-off gain of $97.7M impacting its June 30 2020 financial results.

Growing Profit Margin: AMEH's current net profit margins (3.2%) are higher than last year (1.9%).


Past Earnings Growth Analysis

Earnings Trend: AMEH's earnings have grown by 1.5% per year over the past 5 years.

Accelerating Growth: AMEH's earnings growth over the past year (123.4%) exceeds its 5-year average (1.5% per year).

Earnings vs Industry: AMEH earnings growth over the past year (123.4%) exceeded the Healthcare industry 28%.


Return on Equity

High ROE: AMEH's Return on Equity (22.3%) is considered high.


Next Steps

Financial Health

How is Apollo Medical Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: AMEH's short term assets ($380.5M) exceed its short term liabilities ($152.5M).

Long Term Liabilities: AMEH's short term assets ($380.5M) exceed its long term liabilities ($261.9M).


Debt to Equity History and Analysis

Debt Level: AMEH's debt to equity ratio (57.3%) is considered high.

Reducing Debt: AMEH's debt to equity ratio has increased from 1.4% to 57.3% over the past 5 years.

Debt Coverage: AMEH's debt is well covered by operating cash flow (20.1%).

Interest Coverage: AMEH's interest payments on its debt are well covered by EBIT (6x coverage).


Balance Sheet


Next Steps

Dividend

What is Apollo Medical Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate AMEH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate AMEH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if AMEH's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if AMEH's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of AMEH's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.1yrs

Average management tenure


CEO

Kenneth Sim (66 yo)

1.08yrs

Tenure

US$2,495,730

Compensation

Dr. Kenneth T. Sim, M.D., serves as Co-Chief Executive Officer at Apollo Medical Holdings, Inc. since September 30, 2019. Dr. Simhas been an Executive Chairman of Apollo Medical Holdings, Inc. since Decemb ...


CEO Compensation Analysis

Compensation vs Market: Kenneth's total compensation ($USD2.50M) is about average for companies of similar size in the US market ($USD2.82M).

Compensation vs Earnings: Kenneth's compensation has increased by more than 20% in the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Kenneth Sim
Executive Chairman & Co-Chief Executive Officer1.08yrsUS$2.50m5.16%
$ 33.9m
Thomas Lam
President4.75yrsUS$2.49m5.18%
$ 34.0m
Eric Chin
CFO, Interim Co-COO & Corporate Secretary2.25yrsUS$456.58k0.025%
$ 166.3k
Albert Young WaiChow
Chief Administrative Officer1.08yrsUS$381.41k2.81%
$ 18.4m
Adrian Vazquez
Chief Medical Officerno dataUS$517.06k1.3%
$ 8.5m
Brandon Sim
CTO, VP of Engineering & Interim Co-COO0.42yrno data0.048%
$ 314.2k

1.1yrs

Average Tenure

58yo

Average Age

Experienced Management: AMEH's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Kenneth Sim
Executive Chairman & Co-Chief Executive Officer1.08yrsUS$2.50m5.16%
$ 33.9m
Thomas Lam
President4.75yrsUS$2.49m5.18%
$ 34.0m
Ernest Bates
Independent Director2.33yrsUS$226.08k0%
$ 0
David Schmidt
Independent Director7.42yrsUS$310.08k0%
$ 0
Mark Fawcett
Independent Director4.75yrsUS$322.23k0.083%
$ 542.4k
John Chiang
Independent Director1.75yrsUS$187.00k0.00028%
$ 1.8k
Matthew Mazdyasni
Director1.08yrsUS$218.30kno data
Li Yu
Independent Director2.83yrsUS$221.33k0%
$ 0
Mitchell Kitayama
Lead Independent Directorno dataUS$327.59k0%
$ 0
Michael Eng
Independent Director2.83yrsUS$252.33k0.013%
$ 88.4k
Linda Marsh
Director1.75yrsUS$98.00k1.43%
$ 9.4m

2.8yrs

Average Tenure

70yo

Average Age

Experienced Board: AMEH's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: AMEH insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Apollo Medical Holdings, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Apollo Medical Holdings, Inc.
  • Ticker: AMEH
  • Exchange: NasdaqCM
  • Founded: 1994
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$656.476m
  • Shares outstanding: 36.31m
  • Website: https://www.apollomed.net

Number of Employees


Location

  • Apollo Medical Holdings, Inc.
  • 1668 South Garfield Avenue
  • 2nd Floor
  • Alhambra
  • California
  • 91801
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
AMEHNasdaqCM (Nasdaq Capital Market)YesCommon Stock USUSDDec 2017

Biography

Apollo Medical Holdings, Inc., a physician-centric integrated population health management company, provides medical care services. The company offers care coordination services to principal constituents o ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/10/20 00:18
End of Day Share Price2020/10/19 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.